About this item:

355 Views | 390 Downloads

Author Notes:

Correspondence - William R. Tyor, MD, Neurology (GEC), Atlanta VA Medical Center, 1670 Clairmont Rd., Decatur, GA 30033, (404) 728-7609, Fax: (404) 728-4715, Email: wtor@emory.edu

The authors, Dr. William R. Tyor, Cari Fritz-French, and Dr. Avindra Nath, declare that they have no conflict of interest.

Subjects:

Keywords:

  • HIV encephalitis
  • encephalitis
  • HIV clades
  • HIV associated neurocognitive disorders

Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders

Tools:

Journal Title:

Journal of NeuroVirology

Volume:

Volume 19, Number 6

Publisher:

, Pages 515-522

Type of Work:

Article | Post-print: After Peer Review

Abstract:

The effects of evolutionary pressure on human immunodeficiency virus-1 (HIV) have resulted in a variety of clades and recombinants. The functional implications of HIV clades on disease onset and progression of HIV-associated neurocognitive disorders (HAND) have been suggested by clinical and basic science studies, which will be reviewed in detail. Some clinical studies suggest that patients infected with clade D show the greatest propensity for developing HIV-associated dementia (HAD) followed by clades B, C, and A respectively. However, there are conflicting reports. This review summarizes clinical studies that have assessed behavioral abnormalities and HIV clade type in HAND patients, focusing on the clades stated above. The limitations include variations in testing used to define the cohorts, patient sample size, lack of HIV clade characterization, combination antiretroviral therapy (cART) availability, and other factors, which are highlighted and compared between clinical studies performed primarily in Africa and India. Basic science studies provide substantial evidence that HIV clade differences can result in varying degrees of neuropathology and are also reviewed in some detail. These studies indicate that there are a number of clade differences, most notably in Tat, that result in different degrees of neurovirulence or neuropathological effects in vitro and in a mouse model of HAND. In order to confirm the hypothesis that HIV clade differences are important determinants of HAND pathogenesis, larger, longitudinal studies that employ standard definitions of HAND and HIV clade testing must be performed. In a larger sense, HAND continues to be highly prevalent despite the advent of cART and, therefore, further studies into HAND pathogenesis are critical to develop better therapies.

Copyright information:

© 2013, Journal of NeuroVirology, Inc.

Export to EndNote